A clinical study evaluating the effect of DE111 on digestive health resulted in a significant influence on gut microbiota measured prior to and after capsule consumption (5 billion CFU). Fecal samples showed an increase in the levels of B. subtilis and Bifidobacterium (good bacteria) and a slight decrease in levels of E. coli (bad bacteria). DE111 was also able to maintain healthy levels of cholesterol, glucose, and triglycerides, indicating that DE111 supports the normal breakdown of complex carbohydrates, sugars, and fats.
Consumers are looking for new alternatives to strengthen their immunity, and new understandings related to the microbiome have shed a…More
A clinical study showed a reduction of alternating constipation and diarrhea for the participants taking DE111 (1 billion CFU) when…More
In a study involving 91 children aged 2 to 6, researchers found that daily consumption of the probiotic strain Bacillus subtilis DE111…More